Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing
The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction
Integrated fluorescence light microscope combines light and electron microscopy into one system, removes complication of transferring samples between microscopes
Melanie Thom, owner of Baere Aerospace Consulting, provides advice on how to tackle misinformation in science and how reviews help maximize equipment budget
Dr. Neha Mittal shares the secrets to successful wastewater viral testing at UNCC and discusses the part it could play in controlling future outbreaks
Catch up on this on-demand webinar to learn about early and late-onset neonatal hypocalcemia diagnosis
The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods
Ranya Badran, Corning, discusses the importance of sample preservation over time and reveals state-of-the-art cooling tools that protect precious samples
Dr. Sandra Leibel, USCD and Rady Children’s Hospital, discusses physiologically relevant lung organoids, the power of automated live-cell imaging and the search for new biotherapeutics
Simplified design reduces manufacturing time and offers improved functionality to help streamline antibody discovery, cell line development, cell therapy, and synthetic biology workflows
Bees are in decline because of intensive farming, pesticide prevalence and climate change – but human welfare depends on them
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences
Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more
Genome editing experts harness the power of CRISPR-Cas enzymes to power the next diagnostic revolution in COVID-19 detection and diagnosis
